Page last updated: 2024-09-03

mk 0663 and Polyarthritis

mk 0663 has been researched along with Polyarthritis in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's17 (80.95)29.6817
2010's4 (19.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atre, B; Balap, A; Lohidasan, S; Mahadik, K; Sinnathambi, A1
Arora, SK; Khanduja, KL; Medhi, B; Pandhi, P; Rao, RS; Saikia, UN; Toor, JS1
Diza, E; Gika, HG; Michopoulos, F; Nikolaidis, P; Settas, L; Smith, C; Theodoridis, G; Theodoridou, A; Wilson, ID1
Brater, DC; Cannon, CP; Curtis, SP; Kaur, A; Krum, H; Laine, L; Smugar, SS; Wang, H; Weir, MR1
Cannon, CP; Cryer, B; Curtis, SP; Kaur, A; Laine, L2
Brater, DC; Cannon, CP; Curtis, SP; Gammaitoni, A; Kaur, A; Krum, H; Laine, L; Peloso, PM; Smugar, SS; Swergold, G; Wang, H; Weir, MR1
Cochrane, DJ; Jarvis, B; Keating, GM1
Capell, HA; Duncan, MR1
Cavanaugh, PF; Matsumoto, AK1
Cavanaugh, PF; Dougados, M; Gossec, L; James, MK; Krupa, DA; Melian, A; Reicin, AS; van der Heijde, D1
Martina, SD; Ripley, TL; Vesta, KS1
Krüger, K1
Lee, W; Weisman, MH1
Broich, K; Heim, HK1
Patrignani, P; Rodríguez, LA1
Tabrizchi, R1
Young, D1
Navarra, S; Rubin, BR; Smugar, SS; Tershakovec, AM; Yu, Q1
Nikkels, AF; Piérard, GE; Thirion, L1

Reviews

5 review(s) available for mk 0663 and Polyarthritis

ArticleYear
Etoricoxib.
    Drugs, 2002, Volume: 62, Issue:18

    Topics: Administration, Oral; Arthritis; Back Pain; Clinical Trials as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Gout; Humans; Isoenzymes; Membrane Proteins; Oral Surgical Procedures; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones

2002
Etoricoxib.
    Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40, Issue:5

    Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones

2004
Etoricoxib: a highly selective COX-2 inhibitor.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:5

    Topics: Adult; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Dysmenorrhea; Etoricoxib; Female; Half-Life; Humans; Low Back Pain; Male; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfones

2005
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
    MMW Fortschritte der Medizin, 2005, Aug-04, Volume: 147, Issue:31-32

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones

2005
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Lancet (London, England), 2007, Feb-10, Volume: 369, Issue:9560

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyridines; Sulfones

2007

Trials

6 trial(s) available for mk 0663 and Polyarthritis

ArticleYear
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
    European journal of heart failure, 2009, Volume: 11, Issue:6

    Topics: Aged; Arthritis; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Etoricoxib; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Pyridines; Retrospective Studies; Risk Factors; Sulfones

2009
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyridines; Risk Factors; Sulfones; Time Factors; Upper Gastrointestinal Tract

2010
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.
    Cardiovascular therapeutics, 2012, Volume: 30, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Body Weight; Comorbidity; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Pyridines; Racial Groups; Risk Assessment; Sulfones; Thrombosis

2012
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
    Annals of the rheumatic diseases, 2005, Volume: 64, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Pain Measurement; Pyridines; Severity of Illness Index; Spondylitis, Ankylosing; Sulfones; Treatment Outcome

2005
Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis.
    Nature clinical practice. Rheumatology, 2006, Volume: 2, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Follow-Up Studies; Humans; Naproxen; Pain Measurement; Pyridines; Spondylitis, Ankylosing; Sulfones; Treatment Outcome

2006
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
    Current medical research and opinion, 2007, Volume: 23, Issue:7

    Topics: Acute Disease; Adult; Arthralgia; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Resistance; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones

2007

Other Studies

10 other study(ies) available for mk 0663 and Polyarthritis

ArticleYear
[Non-selective NSAIDs and coxibs: what are myths, what are facts?].
    MMW Fortschritte der Medizin, 2013, Jun-27, Volume: 155, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Humans; Long-Term Care; Osteoarthritis; Pain; Pain Management; Pyridines; Sulfones; Treatment Outcome

2013
Pharmacokinetic and pharmacodynamic herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide with etoricoxib after oral administration in rats.
    Journal of ethnopharmacology, 2016, May-13, Volume: 183

    Topics: Administration, Oral; Andrographis; Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis; Chromatography, High Pressure Liquid; Diterpenes; Etoricoxib; Female; Herb-Drug Interactions; Plant Extracts; Plants, Medicinal; Pyridines; Rats; Rats, Wistar; Sulfones

2016
Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:10

    Topics: Acetic Acid; Analysis of Variance; Animals; Arthritis; Colitis; Cyclooxygenase Inhibitors; Cytokines; Disease Models, Animal; DNA Fragmentation; Etoricoxib; Freund's Adjuvant; Immunosuppressive Agents; Inflammation; Male; Pyridines; Rats; Rats, Wistar; Seizures; Sulfones; Thalidomide

2008
Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2009, Apr-05, Volume: 49, Issue:3

    Topics: Adult; Aged; Arthritis; Celecoxib; Chromatography, High Pressure Liquid; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Humans; Male; Mass Spectrometry; Middle Aged; Pyrazoles; Pyridines; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Sulfones; Synovial Fluid; Young Adult

2009
Etoricoxib in the treatment of chronic pain.
    International journal of clinical practice, 2003, Volume: 57, Issue:4

    Topics: Adult; Aged; Arthritis; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Gastrointestinal Diseases; Humans; Low Back Pain; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones

2003
Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspects.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Animals; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Evaluation, Preclinical; Etoricoxib; European Union; Humans; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Sulfones; Thromboembolism

2006
The ever growing story of cyclo-oxygenase inhibition.
    Lancet (London, England), 2006, Nov-18, Volume: 368, Issue:9549

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Humans; Pyridines; Randomized Controlled Trials as Topic; Sulfones

2006
Coxibs: can this class of drugs survive?
    Vascular health and risk management, 2005, Volume: 1, Issue:1

    Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Etoricoxib; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Lactones; Patient Selection; Pyrazoles; Pyridines; Sulfonamides; Sulfones

2005
Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, May-15, Volume: 64, Issue:10

    Topics: Arthritis; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Industry; Etoricoxib; Humans; Pyridines; Sulfones; United States; United States Food and Drug Administration

2007
Etoricoxib-induced erythema-multiforme-like eruption.
    Dermatology (Basel, Switzerland), 2008, Volume: 216, Issue:3

    Topics: Aged; Arthritis; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Erythema Multiforme; Etoricoxib; Humans; Male; Pyridines; Skin; Sulfones

2008